Recently Updated Advisory Committee Materials: Pediatric Advisory Committee

Recently Updated Advisory Committee Materials

- - Posted on May 12, 2011

Pediatric Advisory Committee

Lexapro Article: Suicide and Antidepressants. Beware extrapolation from ecological data (Reference)1



Briefing Materials for the May 16, 2011 Meeting of the Pediatric Advisory Committee2



Lexapro: Use Review3 (PDF - 53KB)

Patanase: Use Review4 (PDF - 66KB)

Topical Calcineurin Inhibitors: Safety Review Follow-Up5 (PDF - 139KB)

Astepro: Use Review6 (PDF - 51KB)

Crestor: Use Review7 (PDF - 70KB)

Cetraxal: Use Review8 (PDF - 46KB)

Lexapro: Safety Review9 (PDF - 186KB)

Topical Calcineurin Inhibitors: Literature Review10 (PDF - 351KB)

Bepreve: Safety Review11 (PDF - 79KB)

Actonel: Safety Review12 (PDF - 85KB)

Intuniv: Safety Review13 (PDF - 173KB)

Welchol: Use Review14 (PDF - 70KB)

Memo From Dr. Dianne Murphy, Director of the Office of Pediatric Therapeutics, to the Committee15 (PDF - 22KB)

Actonel: Use Review16 (PDF - 65KB)

Astepro: Safety Review17 (PDF - 123KB)

Bepreve: Use Review18 (PDF - 54KB)

Crestor: Medication Error Review19 (PDF - 38KB)

Valcyte: Statistical Review20 (PDF - 19KB)

Cetraxal: Safety Review21 (PDF - 29KB)

Topical Calcineurin Inhibitors: Literature Review Addendum22 (PDF - 97KB)

Welchol: Safety Review23 (PDF - 90KB)

Hiberex: Safety and Utilization Review24 (PDF - 38KB)

Besivance: Use Review25 (PDF - 49KB)

Patanase: Safety Review26 (PDF - 138KB)

Besivance: Safety Review27 (PDF - 83KB)

Crestor: Safety Review28 (PDF - 91KB)

Valcyte: Use Review29 (PDF - 65KB)

Intuniv: Use Review30 (PDF - 66KB)

Valcyte: Safety Review31 (PDF - 166KB)



open here to download the files:

Recently Updated Advisory Committee Materials